Cargando…

Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance

BRAF is prototypical of oncogenes that can be targeted therapeutically and the treatment of BRAF(V600E) melanomas with RAF and MEK inhibitors results in rapid tumor regression. However, drug‐induced rewiring generates a drug adapted state thought to be involved in acquired resistance and disease rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröhlich, Fabian, Gerosa, Luca, Muhlich, Jeremy, Sorger, Peter K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912026/
https://www.ncbi.nlm.nih.gov/pubmed/36700386
http://dx.doi.org/10.15252/msb.202210988